www.ftc.gov/enforcement/cases-proceedings/141-0134/sun-pharmaceutical-industries-ltd-et-al-matter

Mar 20, 2015 ... Torrent Pharmaceuticals Ltd., a global drug company based in India that markets generic drugs in the United States, will acquire the divested ...

www.law360.com/companies/novartis-ag

The latest litigation news, cases and dockets involving the company Novartis AG (NYSE:NVS) ... Cases (4871). January 9, 2019 | New Jersey SUN PHARMACEUTICAL INDUSTRIES LIMITED v. NOVARTIS PHARMACEUTICALS CORP. et al.

economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-rises-with-rd-and-bets-on-specialty-drugs/articleshow/64458050.cms

Jun 5, 2018 ... Sun Pharma- India's largest drug maker - is vying for its share in the ... When ET sought responses on its strategy, Sun Pharma the company ... Novartis, Eli Lilly are ensconced in the drug segment and Sun is ... area for a small entry into the US branded or specialty drugs business. .... Ltd. All rights reserved.

www.ptablitigationblog.com/wp-content/uploads/2018/07/Novartis-v.-Apotex-Gilenya.pdf

Jul 11, 2018 ... Pharmaceutical Industries, Inc., and Sun Pharma Global FZE (collectively, ... Patent 9,187,405 to Novartis Pharmaceuticals Corporation (see Assignment ... administrative matters that would affect, or be affected by, a decision in this .... 11 Kappos et al., “A Placebo-Controlled Trial of Oral Fingolimod in.

patentdocs.typepad.com/files/sun-pharma_ipr2017-01929_institution.pdf

... INC., and. SUN PHARMA GLOBAL FZE,. Petitioner, v. NOVARTIS AG,. Patent Owner. ... Sun Pharmaceutical Industries, Ltd., Sun Pharmaceutical Industries,. Inc., and Sun ... In IPR2017-00854, Apotex, Inc. and Apotex Corp. (collectively, ... 5 Kappos et al., “A Placebo-Controlled Trial of Oral Fingolimod in Relapsing ...

www.sunpharma.com/Media/Press-Releases/Press%20Release%20Sun%20Pharma%20to%20acquire%20branded%20oncology%20product%20Odomzo%C2%AE%20for%20global%20markets.pdf

Dec 22, 2016 ... Odomzo® extends Sun Pharma's commitment in dermatology ... Sun Pharmaceutical Industries Ltd and includes its subsidiaries or ... plans to acquire a branded oncology product, Odomzo, from Novartis. ... pharmaceutical company and India's top pharmaceutical company. ... 1 Dummer R et al, ASCO 2016.

eplaw.org/nl-sun-v-novartis

Posted: April 11th, 2017. Sun Pharmaceutical Industries (Europe) B.V. v. Novartis AG, Novartis Pharma GmbH, District Court The Hague, 5 April 2017, Case No.

www.globalacademycme.com/cme/dermatology-skin-disease-education-foundation/new-treatment-paradigms-psoriasis-understanding/evolving-landscape-psoriasis-treatment/page/0/1

... patients adequately about the optimal use of medications or about what to expect from treatment. ... Speakers Bureau: AbbVie Inc., Eli Lilly and Company, Janssen Biotech, Inc. ... Dermira,Inc.,Eli Lilly and Company, LEO Pharma Inc., Novartis Pharmaceuticals Corporation, Pfizer Inc., Sun Pharmaceutical Industries Ltd., ...

www.marketwatch.com/investing/stock/524715?countrycode=in

Sun Pharmaceutical Industries Ltd. stock price, stock quotes and financial overviews from ... 668.8% vs Avg. ... Apr. 8, 2017 at 11:33 a.m. ET; by Emma Court. Sun Pharma to buy Ranbaxy in $3.2 billion deal ... Novartis India Ltd. -0.55 %, ₹18.04B ... El Chapo's Wife is Flaunting Her Wealth While He's on Trial NYPost.com. ×.